BEATWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BEAT

HeartBeam, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.02+0.02 (+551.61%)

Close on Oct 19, 2026

Market cap: $1.07M
P/E (TTM): –
Dividend yield: –

HeartBeam, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Research & Development	13	11	6.80	5.68	0.26	0.13
General & Administrative	7.69	8.84	8.52	7.35	2.03	0.66
Operating Expenses	21	20	15	13	2.29	0.79
Operating Income	-21	-20	-15	-13	-2.29	-0.79
Interest Expense	–	–	–	–	2.17	0.28
Other Non-Operating Income	0.12	0.44	0.68	0.07	-2.14	-0.28
Pretax Income	-21	-19	-15	-13	-4.43	-1.07
Income Tax Expense	0	0	0	0	0	0
Income from Continuing Operations	-21,015	-19,448	–	–	–	–
Net Income	-21	-19	-15	-13	-4.43	-1.07
EPS (Basic)(per share)	-0.62	-0.73	-0.72	-1.59	-1.03	-0.29
EPS (Diluted)(per share)	-0.62	-0.73	-0.72	-1.59	-1.03	-0.29
Shares Outstanding (Basic, Weighted)(shares)	34	27	20	8.17	4.28	3.65
Shares Outstanding (Diluted, Weighted)(shares)	34	27	20	8.17	4.28	3.65

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -987.3%

Financial strength

Current ratio: 3.66
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 354.6%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.13
Dividend yield: –